Biomet reports loss on special charges-WEB ONLY
Biomet Inc. yesterday reported a $170.9 million loss in its fiscal fourth quarter as the result of more than $300 million in special charges. For the period ended May 31, the Warsaw-based manufacturer of orthopedic products reported $103 million in charges related to its 2007 merger with LVB Acquisition LLC, a private-equity consortium partly managed […]